Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3015948 | Revista Española de Cardiología | 2007 | 4 Pages |
Abstract
Low-output syndrome is one of the leading causes of death following open-heart surgery or high-risk angioplasty. Ventricular assist devices have been used to treat patients who suffer from postoperative cardiogenic shock despite use of an intraaortic balloon pump and maximum inotropic support. The Impella pump (Impella Cardiosystems AG, Aachen, Germany) is a newly introduced left ventricular assist device that has been shown to reduce infarct size and to accelerate recovery of stunned myocardium. We report our initial experience using the Impella device for the treatment of cardiogenic shock following cardiopulmonary bypass and for maintaining hemodynamic stability in high-surgical-risk patients undergoing unprotected left coronary artery angioplasty.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
VÃctor Bautista-Hernández, Francisco Gutiérrez, Eduardo Pinar, Juan R. Gimeno, José M. Arribas, Julio GarcÃa-Puente, Victor G. Ray, Ramón Arcas, Mariano Valdés,